ArticleNeuro-oncology2012
Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria.
Jaime Gállego Pérez-Larraya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
60 papers cite it
this paperpooled ittrialcites it